Benign prognosis in idiopathic hyper-CK-emia

Muscle and Nerve

Volumn 23, Issue 4, 2000, Pages 575-579

  Reijneveld, Jaap C ^a   Notermans, Nicolette C ^a   Linssen, Wim H J P ^b   Wokke, John H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Creatine kinase; Exercise; Follow up; Idiopathic hyper CK emia; Myopathy

Indexed keywords

CREATINE KINASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; ELECTROMYOGRAM; ENZYME DEFECT; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; SENSORY NEUROPATHY;

ADOLESCENT; ADULT; CREATINE KINASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; NEUROMUSCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0034122729     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(200004)23:4<575::AID-MUS17>3.0.CO;2-5     Document Type: Article

References (23)

1. Ausems MGEM, Lochman P, van Diggelen OP, Ploos van Amstel HK, Reuser AJJ, Wokke JHJ. A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology 1999; 52:851-853.
2. Bär PR, Reijneveld JC, Wokke JHJ, Jacobs SCJM, Bootsma AL. Muscle damage induced by exercise: nature, prevention and repair. In: Salmons S, editor. Muscle damage. Oxford: Oxford University Press; 1997. p 1-27.
3. Brewster LM, Visser de M. Persistent hyperCKemia: fourteen patients studied in retrospect. Acta Neurol Scand 1988;77: 60-63.
4. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 1981;4:186-197.
5. Duggan DJ, Gorospe R, Fanin M, Hoffmann EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 1997; 336:618-624.
6. Hagberg M, Michaelson G, Ortelius A. Serum creatine kinase as an indicator of local muscular strain in experimental and occupational work. Int Arch Occup Environ Health 1982;50: 377-386.
7. Imai Y, Watanabe N, Hashimoto J, Nishiyama A, Sakuma H, Sekino H, Omata K, Abe K. Muscle cramps and elevated serum creatine phosphokinase levels induced by b-adrenoceptor blockers. Eur J Clin Pharmacol 1995;48:29-34.
8. Kleppe B, Reimers CD, Altmann C, Pongratz DE. Befunde bei 100 Patienten mit "atiologisch ungeklärter" Erhöhung de Serumkreatinkinaseaktivität. Med Klin 1995;90:623-627.
9. Linssen WHJP, Notermans NC, Graaf van der Y, Wokke JHJ, Doom van PA, Höweler CJ, Busch HFM, Jager de AEJ, Visser de M. Miyoshi-type distal muscular dystrophy; clinical spectrum in 24 Dutch patients. Brain 1997;120:1989-1996.
10. London SF, Gross KF, Ringel SP. Cholesterol-lowering agent myopathy (CLAM). Neurology 1991;41:1159-1160.
11. Prelle A, Rigoletto C, Moggio M, Sciacco M, Comi GP, Ciscato P, Fagiolari G, Rapuzzi S, Bignotti V, Scarlato G. Asymptomatic familiar hyper-CK-emia associated with desmin accumulation in skeletal muscle. J Neurol Sci 1996;140:132-136.
12. Reijneveld JC, Ferrington DA, Amelink GJ, Bär PR. Estradiol treatment reduces structural muscle damage after exercise in male rats. Med Sci Sports Exerc 1994;26:S94.
13. Reijneveld JC, Koot RW, Bredman JJ, Joles JA, Bär PR. Young rats develop myopathy at lower doses of HMG-CoA-reductase inhibitors than adult animals. Ped Res 1995;39:1028-1035.
14. Rowland LP, Willner J, Cerri C, DiMauro S, Miranda A. Approaches to the membrane theory of Duchenne muscular dystrophy. In: Angelini C, Danielli GA, Fontanari D, editors. Muscular dystrophy research: advances and new trends. Amsterdam: Excerpta Medica; 1980. p 3-13.
15. Samaha FJ, Quinlan JG. Myalgia and cramps: dystrophinopathy with wide-ranging laboratory findings. J Child Neurol 1996;11:21-24.
16. Scelsa SN, Simpson DM, McQuistion HL, Fineman A, Ault K, Reichler B. Clozapine-induced myotoxicity in patients with chronic psychotic disorders. Neurology 1996;47:1518-1523.
17. Shumate JB, Katnik R, Ruiz M, Kaiser K, Frieden C, Brooke MH, Carroll JE. Myoadenylate deaminase deficiency. Muscle Nerve 1979;2:213-216.
18. Simms RW. Fibromyalgia is not a muscle disorder. Am J Med Sci 1998;6:346-350.
19. Sunohara N, Takagi A, Nonaka I, Sugita H, Satoyoshi E. Idiopathic hyperCKemia. Neurology 1984;34:544-547.
20. Swieten van JC, Koudstaal PJ, Visser MC, Schouten HJA, Gijn van J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
21. Tancredi L, Prelle A, Battistel A, Sciacco M, Comi GP, Ciscato P, Bordoni A, Fortunato F, Robotti M, Chiveri L, Napoli L, Bresolin N, Scarlato G, Moggio, M. Retrospective study of a large population of patients with asymptomatic or paucisymptomatic elevation of creatine kinase serum levels. J Neurol 1998;245:426.
22. Teunissen LL, Notermans NC, Franssen H, Graaf van der Y, Oey PL, Linssen WHJP, Engelen van BGM, Ippel PF, Dijk van GW, Gabreëls-Festen AAWM, Wokke JHJ. Differences between hereditary motor and sensory neuropathy type 2 and chronic idiopathic axonal neuropathy: a clinical and electrophysiological study. Brain 1997;120:955-962.
23. Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg 1997;84:1038-1041.